Skip to main content
Signal8

Olafsson Sigurdur O

SEC insider (Form 3/4/5 filer). CIK 0001499481. President and CEO at Keenova Therapeutics plc (NONE). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 25, 2026. Located in BRIDGEWATER, NJ.

Companies Olafsson Sigurdur O has filed insider reports for

  • Keenova Therapeutics plc (NONE): Director, Officer, President and CEO
Olafsson Sigurdur O profile photo

Olafsson Sigurdur O

CIK: 0001499481

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (25.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)3 (37.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Keenova Therapeutics plc logo
NONE

Keenova Therapeutics plc

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Keenova Therapeutics plc logo
    No ticker

    Keenova Therapeutics plc

    Feb 25, 2026
    Award

    Restricted Stock Units

    Direct
    198.5K shares-
  • No ticker

    Keenova Therapeutics plc

    Jan 1, 2026
    Exercise
    Direct
    32.9K shares-
  • No ticker

    Keenova Therapeutics plc

    Jan 1, 2026
    Tax Payment
    Direct
    16.9K shares-
  • No ticker

    Mallinckrodt plc

    Aug 14, 2025
    Award

    Restricted Stock Units

    Direct
    65K shares-
  • No ticker

    Mallinckrodt plc

    Jul 31, 2025
    Award

    Restricted Stock Units

    Direct
    164.1K shares-
  • Mallinckrodt plc logo
    No ticker

    Mallinckrodt plc

    Jan 1, 2025
    Tax Payment
    Direct
    11.6K shares-
  • Mallinckrodt plc logo
    No ticker

    Mallinckrodt plc

    Jan 1, 2025
    Tax Payment
    Direct
    11.6K shares-
  • Mallinckrodt plc logo
    No ticker

    Mallinckrodt plc

    Jan 1, 2025
    Exercise
    Direct
    27.4K shares-

1-8 of 8